Intuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.
Follow ISRG
Intuitive Surgical, Inc. (ISRG) EV/FCF
As of 16 October 2026, Intuitive Surgical, Inc. (ISRG) trades at a EV/FCF of 44.6×. Over the past ten years it has ranged from 20.9× (January 2017) to 407× (September 2024); the current reading is higher than 29% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 78.8× | (43.38%) |
| FY2024 | 139× | (6.06%) |
| FY2023 | 148× | 57.07% |
| FY2022 | 94.3× | 33.34% |
| FY2021 | 70.7× | (10.80%) |
| FY2020 | 79.3× | 43.02% |
| FY2019 | 55.4× | 5.94% |
| FY2018 | 52.3× | 24.83% |
| FY2017 | 41.9× | 96.60% |
| FY2016 | 21.3× | (17.32%) |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | 41.5× | (24.89%) |
| Mar 2026 | 55.2× | (29.88%) |
| Dec 2025 | 78.8× | 15.75% |
| Sep 2025 | 68.1× | (28.37%) |
| 42 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| SOLV Solventum Corporation compare | −167× |
| MDLN Medline Inc. compare | 17.7× |
| BDX Becton, Dickinson and Company compare | 20.4× |
| RMD ResMed Inc. compare | 20.7× |
| ALC Alcon compare | 22.3× |
| BAX Baxter International Inc. compare | 25.0× |
| ISRG Intuitive Surgical, Inc. | 44.6× |
| WST West Pharmaceutical Services, Inc. compare | 62.1× |
| RGEN Repligen Corporation compare | 159× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on ISRG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement